Matinas BioPharma updates corporate presentation; no specifics available

Matinas BioPharma Holdings, Inc.

Corporate presentation updated as of November 20, 2023.
Presentation intended for use at conferences and investor meetings.
Exhibit 99.1 attached; full content not provided in accessible text.

item 7.01 item 9.01

Matinas BioPharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-041978

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.